SERA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SERA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sera Prognostics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $64.75 Mil. Sera Prognostics's Total Assets for the quarter that ended in Mar. 2024 was $89.89 Mil.
The historical rank and industry rank for Sera Prognostics's Equity-to-Asset or its related term are showing as below:
During the past 5 years, the highest Equity to Asset Ratio of Sera Prognostics was 0.98. The lowest was -8.49. And the median was 0.84.
The historical data trend for Sera Prognostics's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sera Prognostics Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Equity-to-Asset | -4.58 | -8.49 | 0.94 | 0.85 | 0.74 |
Sera Prognostics Quarterly Data | ||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Equity-to-Asset | Get a 7-Day Free Trial | 0.85 | 0.84 | 0.84 | 0.74 | 0.72 |
For the Diagnostics & Research subindustry, Sera Prognostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Sera Prognostics's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Sera Prognostics's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Sera Prognostics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Equity to Asset (A: Dec. 2023 ) | = | Total Stockholders Equity | / | Total Assets |
= | 70.158 | / | 95.441 | |
= | 0.74 |
Sera Prognostics's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as
Equity to Asset (Q: Mar. 2024 ) | = | Total Stockholders Equity | / | Total Assets |
= | 64.75 | / | 89.886 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sera Prognostics (NAS:SERA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Thank you for viewing the detailed overview of Sera Prognostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
John J. Boniface | officer: Chief Scientific Officer | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Benjamin Jackson | officer: General Counsel | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Austin Aerts | officer: Chief Financial Officer | 2479 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Robert Gardner Harrison | officer: Chief Information Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Jane F Barlow | director | 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487 |
Michael R Foley | officer: Chief Medical Officer | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 04109 |
Sandra Aj Lawrence | director | C/O EVERGY, INC., 1200 MAIN STREET, KANSAS CITY MO 64105 |
Zhenya Lindgardt | director | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 84109 |
Paul Kearney | officer: Chief Data Officer | 2749 E. PARLEYS WAY, C/O SERA PROGNOSTICS, INC., SALT LAKE CITY UT 84109 |
Kim P. Kamdar | director | C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542 |
Blue Ox Healthcare Partners, Llc | 10 percent owner | 239 DAWSON ROAD, HILLSIDE NY 12529 |
Nichole L. Martin | officer: VP OF Q/R & HIPPA PRIV. OFF | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Marcus Dean Wilson | director | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Joshua Phillips | director | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Nadia Altomare | officer: Chief Commercial Officer | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
From GuruFocus
By PRNewswire • 11-14-2023
By PRNewswire PRNewswire • 06-19-2022
By PRNewswire PRNewswire • 11-09-2022
By PRNewswire PRNewswire • 05-10-2023
By PRNewswire PRNewswire • 05-15-2023
By PRNewswire PRNewswire • 02-15-2023
By PRNewswire PRNewswire • 07-09-2022
By PRNewswire PRNewswire • 06-29-2022
By PRNewswire • 12-06-2023
By PRNewswire PRNewswire • 02-23-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.